 BVI, a leading developer, manufacturer, and marketer of surgical devices for the ophthalmic marketplace, announced today that it has named David Murray as Chief Financial Officer. Most recently, David served as Chief Financial Officer of Alcon AG from 2015 until its 30bn spin-off from Novartis Group 